Ryze Rx review

What it is

Ryze Rx is a prescription telehealth platform running three main verticals — weight loss with compounded semaglutide and tirzepatide, testosterone replacement therapy, and a peptide line naming BPC-157, sermorelin and NAD⁺ — alongside sexual health and hair and skin categories. Its catalog is described as running to roughly thirty-five peptides plus testosterone cypionate and retatrutide. It states that prescriptions come from board-certified physicians licensed in your state, without naming a medical group, and that medication ships from US-licensed compounding pharmacies, without naming one.

How it works

Quiz-led intake into a physician-reviewed prescription, with a 24-hour prescription turnaround advertised, free shipping, FSA/HSA eligibility and care claimed in all fifty states. Included with each prescription, in its own words, are a physician consultation, ongoing clinical support and discreet shipping from a US-licensed pharmacy — a clean statement of what the money covers, and the kind of bundling that removes the usual surprise of a separate consult fee. The problem is everything you would normally read before handing over a health history. The Terms of Service, Privacy Policy and HIPAA notice in the footer are all non-functional, which means there is no published legal entity, no governing law, no arbitration clause and no written refund policy to examine. No medical group is named. No compounding pharmacy is named. No state list exists behind the all-fifty-states claim. And the site displays a self-reported review score and review count, which is not third-party verified and which we do not repeat. For a platform selling injectables on subscription, that is a lot of missing paperwork, and the pricing inconsistency below reads less like a promotion and more like a site nobody is reconciling.

Pricing transparency

We publish no floor for Ryze Rx on any of its three boards, and the reason is that the homepage disagrees with itself in two places at once. The peptide card reads "BPC-157, Sermorelin, NAD+ & more From $149/mo". The testosterone card reads "From $99/mo". The banner running above both advertises GLP-1s from $119 and testosterone from $89. Its weight-loss card says $149 while its record's catalog pull priced the same products at $199 with three-month bundles at $499 and $799. Four numbers, one page, no explanation. Beyond the inconsistency there is a second problem specific to this board: "From $149/mo" is a category-level figure covering BPC-157, sermorelin, NAD⁺ and an unnamed remainder, so even if it were stable it would not tell you what sermorelin costs. A category floor is not a molecule price. Ask, in writing, for the exact monthly charge for the specific molecule and dose you want, and ask what happens to it when your dose changes.

Branded vs compounded

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. Neither the compounding pharmacies nor the prescribing medical group is named, and compounded sterile products are not reviewed by the FDA for purity and potency the way approved drugs are — which is a more serious gap here than usual, because the legal pages that would normally set out responsibility are not published either. On the evidence, the three named peptides span the full range. Sermorelin is a GHRH analogue acting on a real growth-hormone axis, with thin long-term human outcome data. BPC-157 sits at the other end: it is widely sold, it has no controlled human outcome trials, and its tendon, gut and tissue-repair reputation rests on rodent work. Injected NAD⁺ has no controlled human outcome trials either; the oral precursors NR and NMN are the studied forms and what they show is a raised blood level. Its testosterone line is the one item with a large randomised safety base, and it requires ongoing haematocrit, PSA and testosterone monitoring that the site does not describe. Its catalog also lists retatrutide, an investigational molecule with no marketing authorisation anywhere. Individual results vary.

Pros and watch-outs

The evidence behind what Ryze Rx prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• Sermorelin: a real GHRH drug, read against the anti-aging pitch

  An approved growth-hormone-releasing analog with a pediatric track record — and a longevity case built more on biomarkers than outcomes.

• BPC 157: what the evidence actually shows (and what it doesn't)

  The 'healing peptide' has a deep rodent literature and almost no human data. A straight read of where the science stands.

• NAD injections: how to get them near you or online, and what the evidence really says

  Subcutaneous NAD+ injections are sold as a cheaper, at-home alternative to the IV drip — via “near me” clinics or telehealth shipped to your door. They’re compounded, not FDA-approved, and have no outcome trials; oral NR/NMN precursors are the route with the human data.

• NAD+ precursors (NR and NMN): what the human trials actually show

  They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.

• TRT: what testosterone therapy is actually proven to do

  An FDA-approved therapy for diagnosed hypogonadism — with real but moderate benefits (sexual function, mood; not vitality), cardiovascular non-inferiority in TRAVERSE, and a real fertility trade-off.

• TRT and Hematocrit: Why Testosterone Thickens the Blood, and What to Do About It

  Erythrocytosis is the most common lab change on testosterone therapy — predictable, route-dependent, and manageable with monitoring.

How Ryze Rx compares

A few alternatives worth a look, depending on what you’re optimizing for.

• TMTaurus Meds

  Buyers who want the clinician network and pharmacies named and will confirm the recurring charge first

  See Taurus Meds →
• STStackMD

  Buyers who want the vial concentration stated and will do the four-week-cycle maths themselves

  See StackMD →
• PEPeptidesRx

  NAD⁺ buyers who want milligrams and concentration stated, not just a monthly fee

  See PeptidesRx →